Flow cytometric lymphocyte subset enumeration: 10 years of external quality assessment in the Benelux countries
- 11 September 2007
- journal article
- research article
- Published by Wiley in Cytometry Part B: Clinical Cytometry
- Vol. 74B (2) , 79-90
Abstract
A biannual external quality assessment (EQA) scheme for flow cytometric lymphocyte immunophenotyping is operational in the Benelux countries since 1996. We studied the effects of the methods used on assay outcome, and whether or not this EQA exercise was effective in reducing between‐laboratory variation. Eighty test samples were distributed in 20 biannual send‐outs. Per send‐out, 50–71 participants were requested to enumerate CD3+, CD4+, and CD8+T cells, B cells, and NK cells, and to provide methodological details. Participants received written debriefings with personalized recommendations after each send‐out. For this report, data were analyzed using robust multivariate regression. Five variables were associated with significant positive or negative bias of absolute lymphocyte subset counts: (i) platform methodology (i.e., single‐platform assays yielded lower CD4+and CD8+T‐cell counts than did dual‐platform assays); (ii) sample preparation technique (i.e., assays based on mononuclear cells isolation yielded lower T‐cell counts than those based on red cell lysis); (iii) gating strategies based on CD45 and sideward scatter gating of lymphocytes yielded higher CD4+T‐cell counts than those based on “backgating” of lymphocytes guided by CD45 and CD14); (iv) stabilized samples were generally associated with higher lymphocyte subset counts than nonstabilized samples; and (v) laboratory. Platform methodology, sample stabilization, and laboratory also affected assay variability. With time, assay variability tended to decline; this trend was significant for B‐cell counts only. In addition, significant bias and variability of results, independent of the variables tested for in this analysis, were also associated with individual laboratories. In spite of our recommendations, participants tended to standardize their techniques mainly with respect to sample preparation and gating strategies, but less with absolute counting techniques. Failure to fully standardize protocols may have led to only modest reductions in variability of results between laboratories. © 2007 Clinical Cytometry Society.Keywords
This publication has 44 references indexed in Scilit:
- The prognostic role of CD4+ and CD8+ lymphocytes during chemoimmunotherapy in metastatic melanomaMelanoma Research, 2004
- CD45‐assisted PanLeucogating for accurate, cost‐effective dual‐platform CD4+ T‐cell enumerationCytometry, 2002
- Quality control of CD4+ T‐lymphocyte enumeration: Results from the last 9 years of the United Kingdom national external quality assessment scheme for immune monitoring (1993–2001)Cytometry, 2002
- UK NEQAS for leucocyte immunophenotyping: the first 10 yearsJournal of Clinical Pathology, 2001
- Evaluation of TruCount Absolute-Count Tubes for Determining CD4 and CD8 Cell Numbers in Human Immunodeficiency Virus-Positive AdultsClinical and Diagnostic Laboratory Immunology, 2000
- Evaluation of a novel stable whole blood quality control material for lymphocyte subset analysis: Results from the UK NEQAS immune monitoring schemeCytometry, 1996
- Standardization of absolute CD4+ lymphocyte counts across laboratories: An evaluation of the ortho CytoronAbsolute flow cytometry system on normal donorsCytometry, 1995
- Interlaboratory quality assessment of lymphocyte phenotyping. Etalonorme 1990–1992 surveysBiology of the Cell, 1993
- The Prognostic Value of Cellular and Serologic Markers in Infection with Human Immunodeficiency Virus Type 1New England Journal of Medicine, 1990
- T-cell subset alterations in HIV-infected homosexual men: NIAID multicenter AIDS cohort studyClinical Immunology and Immunopathology, 1989